Addressing Socioeconomic Barriers in Myelofibrosis Care


Shawn Griffin, PharmD, BCOP, reviews strategies to tackle socioeconomic challenges in myelofibrosis treatment, covering costs, transportation, language barriers, cultural sensitivity, and patient communication.

This is a video synopsis/summary of a Peer Exchange involving Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA; James Davis, PharmD, BCOP; Victoria Nachar, PharmD, BCOP; Shawn Griffin, PharmD, BCOP; and Robert Mancini, PharmD, BCOP, FHOPA.

In this segment, Mahmoudjafari addresses Griffin regarding the impact of socioeconomic factors on access to myelofibrosis treatments and strategies to address disparities. Griffin, acknowledging the expensive nature of therapies, emphasizes that the cost is often sufficiently addressed through medication access teams and patient assistance programs. He identifies transportation barriers and underscores the role of social workers in facilitating access. Griffin highlights the benefit of telemedicine for monitoring and adherence assessment. Language barriers are discussed, with Griffin advocating for in-person interpreters and cultural sensitivity. He emphasizes the importance of patient education, advocacy, and clear communication channels. The discussion underscores the multifaceted approach needed to overcome socioeconomic barriers, emphasizing patient empowerment, accessibility, and cultural competence.

This summary was AI-generated and reviewed by Pharmacy Times® editorial staff.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.